b 171
Pill imprint b 171 has been identified as Mefloquine hydrochloride 250 mg.
Mefloquine is used in the treatment of malaria prevention; malaria and belongs to the drug class antimalarial quinolines. Risk cannot be ruled out during pregnancy.
Mefloquine 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Mefloquine hydrochloride Images
- Imprint:
-
b 171
- Strength:
- 250 mg
- Color:
- White
- Size:
- 13.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
corn starch
crospovidone
lactose monohydrate
magnesium stearate
microcrystalline cellulose
poloxamer 188
magnesium silicate
- Drug Class:
- Antimalarial quinolines
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Barr Laboratories, Inc.
- National Drug Code (NDC):
- 00555-0171
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-5407 | A S Medication Solutions LLC (repackager) |
| 23490-5858 | Palmetto State Pharmaceuticals Inc (repackager) |
| 21695-0449 | Rebel Distributors Corp (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Mefloquine Hydrochloride resources
- Mefloquine (Wolters Kluwer)
- mefloquine (Cerner Multum)
- mefloquine (Micromedex) - Includes Dosage Information
- Mefloquine Hydrochloride (AHFS DI)
- Mefloquine (FDA)
- Mefloquine Hydrochloride (Wolters Kluwer)
Search Again
